D. Benito

A sequence-dependent paclitaxel/etoposide phase II trial in patients with non-small cell lung cancer.

E. Felip, C. Camps, M. P. López-Cabrerizo, 1997, Seminars in oncology.

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials.

E. Felip, R. Rosell, C. Camps, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Single agent Taxol, 3-hour infusion, in untreated advanced non-small-cell lung cancer.

J. Garcia-conde, R. Rosell, V. Alberola, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel plus doxorubicin in metastatic breast cancer: preliminary analysis of cardiotoxicity.

A. Lluch, B. Massuti, M. Martín, 1997, Seminars in oncology.

Single-agent paclitaxel by 3-hour infusion in the treatment of non-small cell lung cancer: links between p53 and K-ras gene status and chemosensitivity.

R. Rosell, M. Monzó, V. Alberola, 1995, Seminars in oncology.